OCA

Octagon Capital Advisors Portfolio holdings

AUM $799M
1-Year Est. Return 480.2%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+480.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$641M
AUM Growth
+$185M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1
+$8.26M
2
+$6.38M
3
+$4.24M
4
ABVX
Abivax
ABVX
+$3.56M
5
OCUL icon
Ocular Therapeutix
OCUL
+$2.38M

Top Sells

1
+$31.9M
2
+$23.6M
3
+$19.4M
4
TRML
Tourmaline Bio
TRML
+$14.5M
5
NUVB icon
Nuvation Bio
NUVB
+$13.8M

Sector Composition

1 Healthcare 99.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABVX
1
Abivax
ABVX
$9.59B
$112M 17.56%
1,325,000
+58,000
DNTH icon
2
Dianthus Therapeutics
DNTH
$2.39B
$95.1M 14.84%
2,416,667
+75,000
GOSS icon
3
Gossamer Bio
GOSS
$98.3M
$44.8M 7%
17,050,000
-1,300,000
COGT icon
4
Cogent Biosciences
COGT
$6.31B
$41.3M 6.44%
2,874,111
+111,111
AVBP icon
5
ArriVent BioPharma
AVBP
$948M
$36.4M 5.68%
1,971,054
+25,000
OCUL icon
6
Ocular Therapeutix
OCUL
$1.95B
$30.7M 4.79%
2,624,000
+199,000
TSHA icon
7
Taysha Gene Therapies
TSHA
$1.24B
$29.7M 4.63%
9,067,500
-3,525,000
MRUS
8
DELISTED
Merus
MRUS
$29M 4.53%
308,000
-81,000
TRVI icon
9
Trevi Therapeutics
TRVI
$1.53B
$25.8M 4.02%
2,815,000
-857,000
DFTX
10
Definium Therapeutics
DFTX
$1.72B
$25.1M 3.92%
2,130,000
APLS icon
11
Apellis Pharmaceuticals
APLS
$2.68B
$20.4M 3.19%
903,500
KYMR icon
12
Kymera Therapeutics
KYMR
$7.31B
$20.4M 3.18%
360,000
+94,000
CNTA
13
Centessa Pharmaceuticals
CNTA
$3.97B
$20.1M 3.14%
830,000
-200,000
PHVS icon
14
Pharvaris
PHVS
$1.84B
$18M 2.81%
722,595
+50,000
KALV icon
15
KalVista Pharmaceuticals
KALV
$823M
$15.5M 2.42%
1,273,333
CRBP icon
16
Corbus Pharmaceuticals
CRBP
$150M
$14.1M 2.2%
1,115,000
BBOT
17
BridgeBio Oncology
BBOT
$802M
$12.1M 1.89%
1,043,110
+793,110
DBVT
18
DBV Technologies
DBVT
$1.15B
$10.2M 1.59%
1,018,021
NUVB icon
19
Nuvation Bio
NUVB
$2.03B
$9.74M 1.52%
2,633,334
-5,058,000
CDTX
20
DELISTED
Cidara Therapeutics
CDTX
$9.58M 1.49%
+100,000
MAZE
21
Maze Therapeutics
MAZE
$2.19B
$4.61M 0.72%
177,667
NGNE icon
22
Neurogene
NGNE
$364M
$4.37M 0.68%
252,000
-51,000
UNCY icon
23
Unicycive Therapeutics
UNCY
$149M
$4.36M 0.68%
1,000,000
PEPG icon
24
PepGen
PEPG
$428M
$3.23M 0.5%
+700,000
GPCR icon
25
Structure Therapeutics
GPCR
$4.45B
$3.22M 0.5%
+115,000
1
2